Media & Investors

Relay Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights

November 10, 2021

Relay Therapeutics to Announce Third Quarter 2021 Financial Results and Recent Corporate Highlights

November 4, 2021

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

October 12, 2021

Relay Therapeutics Announces Proposed Public Offering of Common Stock

October 11, 2021

Relay Therapeutics Announces Interim Clinical Data that Support RLY-4008 as a Highly Selective FGFR2 Inhibitor

October 8, 2021

Relay Therapeutics Announces Preclinical Data that Support RLY-2608 as the First Known Allosteric Pan-Mutant Selective Inhibitor of PI3Kα

October 7, 2021

Relay Therapeutics to Present Clinical Data on RLY-4008 and Preclinical Data on RLY-2608 at AACR-NCI-EORTC Molecular Targets Conference

September 13, 2021

Relay Therapeutics Announces Corporate Updates and Reports Second Quarter 2021 Financial Results

August 12, 2021

Relay Therapeutics to Announce Second Quarter 2021 Financial Results and Recent Corporate Highlights

August 5, 2021

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

June 2, 2021

Relay Therapeutics to Participate in Fireside Chat at the Cowen 2nd Annual Oncology Innovation Summit

May 14, 2021

Relay Therapeutics Reports First Quarter 2021 Financial Results

May 13, 2021

Relay Therapeutics Strengthens Computational Leadership Team with Addition of Patrick Riley, Ph.D.

May 10, 2021

Relay Therapeutics to Participate in Fireside Chat at Bank of America 2021 Health Care Conference

May 5, 2021

Relay Therapeutics Expands Clinical Leadership Team with Addition of Tara O’Meara and Charles Ferté

May 3, 2021

Relay Therapeutics Extends Leadership in Integrating Computational and Experimental Approaches to Create Precision Medicines by Acquiring ZebiAI

April 16, 2021

Relay Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

March 25, 2021

Relay Therapeutics to Present Preclinical Data on RLY-4008 at AACR Annual Meeting

March 10, 2021

Relay Therapeutics® to Participate in Fireside Chat at Guggenheim Healthcare Talks 2021 Oncology Day

February 4, 2021

Relay Therapeutics® to Present at 39th Annual J.P. Morgan Healthcare Conference

January 6, 2021